An Improved Label-Free Indirect Competitive SPR Immunosensor and Its Comparison with Conventional ELISA for Ractopamine Detection in Swine Urine

Sai Wang, Shuai Zhao, Xiao Wei, Shan Zhang, Jiahui Liu, Yiyang Dong2017 · DOI

TL;DR

Researchers have developed an improved label-free Surface Plasmon Resonance (SPR) immunosensor for detecting ractopamine (RCT) in swine urine. This new method offers significantly lower detection limits and faster analysis times compared to traditional ELISA, making it a promising tool for real-time monitoring of this banned animal growth promoter.

What Problem Does This Paper Address?

Ractopamine (RCT) is a beta-agonist used to promote animal growth, but its use is banned in many countries due to potential health risks to consumers. Efficient and sensitive detection of RCT residues in animal products is crucial for food safety and regulatory compliance. Traditional methods like HPLC and LC-MS/MS are accurate but complex, time-consuming, and expensive. Immunoassays like ELISA are faster and simpler but often require long incubation times and multiple washing steps, limiting their suitability for rapid, on-site screening. This paper aims to address these limitations by developing a more sensitive, faster, and user-friendly SPR-based immunosensor for RCT detection in swine urine.

Methods

The core of this work is the development and optimization of an indirect competitive Surface Plasmon Resonance (SPR) immunosensor. The process involves:

  • Immobilization: Ractopamine-Bovine Serum Albumin (RCT-BSA) conjugate is immobilized onto a CM5 chip surface via amine coupling.
  • Blocking: Unoccupied sites on the chip are blocked with ethanolamine to prevent non-specific binding.
  • Competitive Assay: A mixture of the sample containing ractopamine (RCT) and a primary antibody (anti-RCT mouse monoclonal antibody, Antibody I) is introduced. If RCT is present in the sample, it competes with the immobilized RCT-BSA for binding to Antibody I.
  • Signal Amplification: A secondary antibody (anti-mouse rabbit antibody, Antibody II) is then introduced. This antibody binds to Antibody I that is already bound to either free RCT or immobilized RCT-BSA. This step amplifies the SPR signal.
  • Label-Free Detection: The SPR technique detects changes in the refractive index near the chip surface, which are proportional to the mass of bound molecules. This allows for label-free detection, eliminating the need for enzymatic or fluorescent labels.
  • Optimization: Key parameters such as the concentration of RCT-BSA, coupling pH, dilution ratios of Antibody I and Antibody II, and pre-incubation time of RCT with Antibody I were systematically optimized to maximize sensitivity and minimize non-specific binding.
  • Comparison: The performance of the optimized SPR immunosensor was directly compared with a conventional indirect competitive ELISA for RCT detection in swine urine.

Datasets

The study utilized:

  • Ractopamine (RCT) standards: Used to create calibration curves and determine detection limits.
  • Negative swine urine samples: Used for method validation, recovery studies, and to assess matrix interference.
  • Other $\beta$-agonist drugs (Salbutamol, Clenbuterol): Used to evaluate the specificity of the developed immunosensor.

No new benchmark datasets were introduced; rather, the performance was evaluated against existing analytical methods and a conventional ELISA.

Key Insights and Ideas

  • Secondary Antibody Amplification: Introducing a secondary antibody (Antibody II) significantly improved the sensitivity of the SPR immunosensor. This antibody binds to the primary antibody, effectively increasing the mass detected by SPR and thus amplifying the signal. This is a clever way to enhance signal without resorting to traditional labels.
  • Pre-incubation is Key: Pre-incubating the sample RCT with the primary antibody before introducing it to the sensor surface was crucial for optimizing the competition and improving sensitivity. This allows for a more efficient binding interaction before the analyte reaches the immobilized antigen.
  • Label-Free Advantage: The SPR immunosensor's label-free nature simplifies the assay, reduces reagent costs, and shortens analysis time by eliminating the need for enzymatic reactions or fluorescent detection steps.
  • SPR vs. ELISA: The SPR immunosensor demonstrated clear advantages over ELISA in terms of lower LOD, reduced reagent consumption, faster analysis time, and potential for automation.

Key Results

  • Improved LOD: The optimized SPR immunosensor achieved a Limit of Detection (LOD) of 0.09 ng/mL for RCT in swine urine. This is a significant improvement over the primary SPR immunosensor (0.22 ng/mL) and most other reported methods.
  • Linear Detection Range: The immunosensor provided a linear detection range of 0.3–32 ng/mL, suitable for practical applications.
  • High Specificity: The immunosensor showed excellent specificity for RCT, with minimal cross-reactivity to other $\beta$-agonist drugs like salbutamol and clenbuterol. The IC50 for these interferents was >1 mg/mL, while for RCT it was 1.96 ng/mL.
  • Accurate Recovery: Recovery studies in spiked swine urine samples showed high accuracy, ranging from 101.8% to 106.6%, with low relative standard deviations (RSD < 8%).
  • Faster Analysis: The entire SPR assay, including sample injection and signal generation, can be completed in approximately 11 minutes, a substantial reduction compared to ELISA's overnight incubation steps.
  • Reduced Reagent Consumption: The SPR method requires significantly less reagent volume per sample compared to ELISA.

Limitations and Future Work

  • Matrix Interference: While the study showed minimal matrix interference in pretreated swine urine, the authors acknowledge that complex sample matrices can still pose challenges for biosensor performance. Further validation with a wider range of real-world samples might be necessary.
  • Automation: While the SPR system offers potential for automation, the current study describes manual steps. Future work could focus on fully automating the SPR assay for high-throughput screening.
  • Aptamer Integration: The authors suggest that the design principles using antibody pairs could be extended to other small molecule detections. They also propose exploring aptamer/antibody pairs or aptamer/aptamer pairs for SPR immunosensors, which could offer alternative recognition elements.
  • Real-time Monitoring: The SPR immunosensor's ability to provide real-time data makes it a promising platform for continuous monitoring of RCT, which could be a valuable area for future research.

Summary updated

BibTeX
@misc{wang2017improved,
  author = {Sai Wang and Shuai Zhao and Xiao Wei and Shan Zhang and Jiahui Liu and Yiyang Dong},
  title = {{An Improved Label-Free Indirect Competitive SPR Immunosensor and Its Comparison with Conventional ELISA for Ractopamine Detection in Swine Urine}},
  year = {2017},
  doi = {10.3390/s17030604},
}
Figure